CDA not accepting AYUSH Govt for new bill

medicinesGovt to bring in new Bill for Indian streams of medicines as CDA keeps Ayush sector out of its purview.

With the proposed Central Drug Authority (CDA) excluding the affairs of Ayush sector from its purview, the Centre is planning to bring in a new bill to govern the manufacturing, marketing and other activities of Indian streams of medicines.

“There was a plan to include Ayush also under the CDA. But it did not happen. Now we are planning to draft a bill to govern the Ayush sector. But it will take time as many things are involved,” secretary of Ayush Department Nilanjan Sanyal confirmed to Pharmabiz.

Based on the recommendations of the Mashelkar Committee, the central government introduced the Drugs and Cosmetics (Amendment) Bill, 2007 in the Rajya Sabha in August, 2007. This original bill, among other things, had sought to bring Ayush also under the CDA. This Bill was referred to the Department-related Parliamentary Standing Committee on Health and Family Welfare for examination. The committee made several recommendations including for creation of a separate chapter for regulating medical devices.

Accordingly, Drugs and Cosmetics (Amendment) Bill 2013 was drafted and was tabled in Rajya Sabha last week. However, it had dropped all matters relating to Ayush drugs while incorporating many recommendations including provisions to regulate the clinical trials and exports.

It is learnt that considering the significance and growth of the Ayush sector, the government wants to create a separate regulatory mechanism and rules for Ayurveda, Unani, Siddha and Homoeopathy drugs. The pending proposal for creating the post of Central Drugs Controller for Ayush sector also will be taken up along with this.[Source]

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.